BioLife Solutions to be acquired by Repligen in $1.5B cell therapy deal

Roderick de Greef, CEO of BioLife Solutions. (BioLife Photo) BioLife Solutions , a Bothell, Wash.-based company developing tools for cell and gene therapy, is being acquired for $1.5 billion by the life sciences corporation Repligen. BioLife is a publicly traded business that makes products used by biotech firms to keep living cells alive and healthy while they’re stored, shipped, frozen or thawed for medical therapies.